An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, Elisabetta, Becker, Stephan, Subbarao, Kanta, Kolesnikova, Larissa, Uematsu, Yasushi, Gismondo, Maria Rita, Murphy, Brian R, Rappuoli, Rino +1 more·2004·Nature Medicine

Cited by (690)

Items 501–600 of 690

  1. Mining the human autoantibody repertoire: Isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma
    Roger R. Beerli, Monika Bauer, Andrea Fritzer, Lindsey B. Rosen, Regula B. Buser, Markus Hanner, Melanie Maudrich, Mario Nebenfuehr, Jorge Alejandro Sepulveda Toepfer, Susanne Mangold et al. · 2014 · mAbs
  2. A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells
    Xiaodong Xiao, Yan Chen, Reena Varkey, Nicole L. Kallewaard, Adem C. Koksal, Qing Zhu, Herren Wu, Partha Sarathi Chowdhury, William F. Dall’Acqua · 2016 · mAbs
  3. The potential of antibody-mediated immunity in the defence against biological weapons
    Arturo Casadevall, Liise‐anne Pirofski · 2005 · Expert Opinion on Biological Therapy
  4. Malaria vaccines: immunity, models and monoclonal antibodies
    Lars Hviid, Lea Klingenberg Barfod · 2008 · Trends in Parasitology
  5. Novel human 3-domain disulfide-stabilized antibody fragment against glycoprotein of rabies virus
    Kun Cai, Hui Wang, Shi-zhong Bao, Jing Shi, Xiaojun Hou, Xiang Gao, Hao Liu, Jun Yin · 2008 · Microbes and Infection
  6. Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets
    Lara S. U. Schwab, Sarah L. Londrigan, Andrëw G. Brööks, Aeron C. Hurt, Anshupa Sahu, Yi‐Mo Deng, Jean M. Moselen, Christoph Coch, Thomas Zillinger, Gunther Hartmann et al. · 2022 · Journal of Virology
  7. Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains
    Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F. Nazzari et al. · 2024 · Nature Communications
  8. Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses
    Meghan Sullivan, Kaval Kaur, Noel T. Pauli, Patrick C. Wilson · 2011 · F1000 Biology Reports
  9. Production of antigen-specific human IgGs by in vitro immunization
    Anne Wijkhuisen, Alexandra Savatier, Nelia Cordeiro, M. Léonetti · 2016 · BMC Biotechnology
  10. Emerging infectious diseases: A 10-year perspective from the National Institute of Allergy and Infectious Diseases
    Anthony S. Fauci, Nancy A. Touchette, Gregory K. Folkers · 2005 · International Journal of Risk & Safety in Medicine
  11. Engineering Antibodies for the Treatment of Infectious Diseases
    Gaowei Fan, Jinming Li · 2017 · Advances in experimental medicine and biology
  12. Antibody Response to Severe Acute Respiratory Syndrome‐ Corona Virus 2, Diagnostic and Therapeutic Implications
    Yuval Ishay, Asa Kessler, Asaf Schwarts, Yaron Ilan · 2020 · Hepatology Communications
  13. The increasing importance of the novel Coronavirus
    Mohammad Ridwane Mungroo, Naveed Ahmed Khan, Ruqaiyyah Siddiqui · 2020 · Hospital Practice
  14. Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients
    Akira Iizuka, Masaru Komiyama, Sachiko Tai, Chie Oshita, Ayumi Kurusu, Akiko Kume, Kazumichi Ozawa, Yoji Nakamura, Tadashi Ashizawa, Akifumi Yamamoto et al. · 2010 · Immunology Letters
  15. Anticorps monoclonaux à usage thérapeutique : un peu d'histoire, beaucoup d'ingénierie, et … quelques succès cliniques
    Sophie Sibéril, Charles‐Antoine Dutertre, Charlotte Boix, Jean‐Luc Teillaud · 2005 · Transfusion Clinique et Biologique
  16. Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
    Gisela Nogales‐Gadea, Abhishek Saxena, Carolin Hoffmann, Judith Hounjet, Daniëlle M. Coenen, Peter C. Molenaar, Mario H. Losen, Pilar Martínez‐Martínez · 2015 · Journal of Visualized Experiments
  17. Production of human antibodies by in vitro immunization using a fusion protein containing the transcriptional transactivator of HIV-1
    Mazhoura Ait Mebarek, Anne Wijkhuisen, Karine Adel‐Patient, Patricia Lamourette, M. Léonetti, Hervé Volland · 2013 · Journal of Immunological Methods
  18. Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning
    Akira Iizuka, Masaru Komiyama, Chie Oshita, Akiko Kume, Tadashi Ashizawa, Koichi Mitsuya, Nakamasa Hayashi, Yoko Nakasu, Ken Yamaguchi, Yasuto Akiyama · 2014 · Immunology Letters
  19. Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection
    Antonella Cerino, Stefania Mantovani, Dalila Mele, Barbara Oliviero, Stefania Varchetta, Mario Umberto Mondelli · 2019 · Frontiers in Immunology
  20. Glycan Nanostructures of Human Coronaviruses
    Wanru Guo, Harini Lakshminarayanan, Alexander Rodriguez‐Palacios, Robert A. Salata, Kaijin Xu, Mohamed Shehata Draz · 2021 · International Journal of Nanomedicine
  21. Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
    Mikako Ueno, Naoko Iwata‐Yoshikawa, Akihiro Matsunaga, Tadashi Okamura, Sho Saito, Shinobu Ashida, Isao Yoshida, Mami Nagashima, Hiroyuki Asakura, Yu Yaoita et al. · 2022 · Antiviral Research
  22. Immunology to Immunotherapeutics of SARS-CoV-2: Identification of Immunogenic Epitopes for Vaccine Development
    Apoorva Pandey, Riya Madan, Swati Singh · 2022 · Current Microbiology
  23. Neutralizing the MERS Coronavirus Threat
    Bart L. Haagmans, Albert D. M. E. Osterhaus · 2014 · Science Translational Medicine
  24. Neutralizing Capacity of Monoclonal Antibodies That Recognize Peptide Sequences Underlying the Carbohydrates on gp41 of Simian Immunodeficiency Virus
    José M. Martinez-Navío, Ronald C. Desrosiers · 2012 · Journal of Virology
  25. Anticorps monoclonaux : tours et détours technologiques pour de nouveaux espoirs thérapeutiques
    Dominique Bourel, Jean‐Luc Teillaud · 2006 · Comptes Rendus Biologies
  26. Immunotherapy for Alzheimer‘s Disease
    Michael O Steinitz · 2009 · Immunotherapy
  27. Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors
    Raiees Andrabi, Rajesh Kumar, Manju Bala, Ambili Nair, Ashutosh Biswas, Naveet Wig, Pratik Kumar, Rahul Pal, Subrata Sinha, Kalpana Luthra · 2012 · Virology Journal
  28. Next-Generation Techniques for Discovering Human Monoclonal Antibodies
    А А Лушова, Maria G. Byazrova, Alexey G. Prilipov, Г. К. Садыкова, Arthur Tigranovich Kopylov, Alexander V. Filatov · 2017 · Molecular Biology
  29. Targeting SARS‐CoV‐2 RBD Interface: a Supervised Computational Data‐Driven Approach to Identify Potential Modulators
    Maria Rita Gulotta, Jessica Lombino, Ugo Perricone, Giada De Simone, Nedra Mekni, Maria De Rosa, Patrizia Diana, Alessandro Padova · 2020 · ChemMedChem
  30. COVID-19 knowledge deconstruction and retrieval: an intelligent bibliometric solution
    Mengjia Wu, Yi Zhang, Mark Markley, Caitlin Cassidy, Nils C. Newman, Alan L. Porter · 2023 · Scientometrics
  31. Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection
    Zoë L. Lyski, William B. Messer · 2019 · Frontiers in Immunology
  32. Evaluation of EBV transformation of human memory B-cells isolated by FACS and MACS techniques
    Sanam Sadreddini, Farhad Jadidi‐Niaragh, Vahid Younesi, Tala Pourlak, Amir Afkham, Fazel Shokri, Mehdi Yousefi · 2016 · Journal of Immunotoxicology
  33. Isolation and characterization of an HIV-1 envelope glycoprotein-specific B-cell from an immortalized human naïve B-cell library
    Zehua Sun, Shiqiang Lu, Zheng Yang, Jingjing Li, Mei-Yun Zhang · 2017 · Journal of General Virology
  34. Monoclonal antibodies: Emergence, present and outlook
    Ji Gao, Juan He, Qingwen Wang, Wanli Liu · 2020 · Chinese Science Bulletin (Chinese Version)
  35. Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
    Walker, Melanie R., Underwood, Alexander, Björnsson, Kasper H., Raghavan, Sai Sundar Rajan, Bassi, Maria R., Binderup, Alekxander, Pham, Long V., Ramirez, Santseharay, Pinholt, Mette, Dagil, Robert et al. · 2024 · Communications Biology
  36. The first WHO reference panel for Infliximab anti-drug antibodies: a step towards harmonizing therapeutic drug monitoring
    Meenu Wadhwa, Isabelle Cludts, Eleanor Atkinson, Peter Rigsby · 2025 · Frontiers in Immunology
  37. Genotype-specific neutralization determinants in envelope protein: implications for the improvement of Japanese encephalitis vaccine
    Qing Ye, Yan‐Peng Xu, Yu Zhang, Xiaofeng Li, Hong-Jiang Wang, Zhongyu Liu, Shihua Li, Long Liu, Hui John Zhao, Qing-Gong Nian et al. · 2015 · Journal of General Virology
  38. Characterization of sentinel node-derived antibodies from breast cancer patients
    Girja S. Shukla, Stephanie C. Pero, Yujing Sun, Chelsea L. Carman, Seth P. Harlow, David N. Krag · 2018 · Journal of Immunological Methods
  39. Antibodies, repertoires and microdevices in antibody discovery and characterization
    Luca Johannes Schlotheuber, Ines Lüchtefeld, Klaus Eyer · 2024 · Lab on a Chip
  40. Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose?
    Anna M. Ehlers, Constance F. den Hartog Jager, Tineke Kardol‐Hoefnagel, Miriam Katsburg, André C. Knulst, Henny G. Otten · 2021 · Frontiers in Immunology
  41. Degenerate primer design to clone the human repertoire of immunoglobulin heavy chain variable regions
    Ying Sun, Hong-Yan Liu, Ling Mu, Enjie Luo · 2011 · World Journal of Microbiology and Biotechnology
  42. Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
    Yinan Xiao, Hanyue Xu, Wen Qiang Guo, Yunuo Zhao, Yuling Luo, Ming Wang, Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng et al. · 2020 · Molecular Biomedicine
  43. Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus
    Ruifeng Chen, Hu Li, Wuyang Zhu, Hongbin Cheng, Yu Li, Xiaomei Li, Faliang Li, Xiaoqiang Liu, Shixiong Hu, Baigang Yan et al. · 2023 · Expert Opinion on Drug Safety
  44. Human Lymphoblastoid Cell Lines in Pharmacogenomics
    Jae‐Pil Jeon · 2014 · Elsevier eBooks
  45. Antigen-Specific Monoclonal Antibodies Isolated from B Cells Expressing Constitutively Active STAT5
    Ferenc A. Scheeren, Caroline M. M. van Geelen, Etsuko Yasuda, Hergen Spits, Tim Beaumont · 2011 · PLoS ONE
  46. Immune titers of protection against severe acute respiratory syndrome coronavirus 2: are we there yet?
    Yoanna Slabakova, Dilyana Gerenska, Nedelcho Ivanov, Tsvetelina Veselinova Velikova · 2022 · Exploration of Immunology
  47. Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections
    Iuliia A. Merkuleva, Д. Н. Щербаков, A. A. Ilyichev · 2022 · Russian Journal of Bioorganic Chemistry
  48. Fungal Vaccines and Vaccination: Problems and Perspectives
    Antonio Cassone · 2007 · Springer eBooks
  49. Cellular and Molecular Basis of Antibody-Dependent Enhancement in Human Dengue Pathogenesis
    Xia Jin · 2008 · Future Virology
  50. Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma Cells
    Davide Corti, Antonio Lanzavecchia · 2015 · ASM Press eBooks
  51. Severe acute respiratory syndrome (SARS)
    Susan Marie Poutanen, Allison McGeer · 2015 · AccessScience
  52. A Highly Potent Antibody Effective Against SARS-CoV-2 Variants of Concern
    Craig W. Fenwick, Priscilla Turelli, Laurent H. Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, Jérémy Campos, Erica Lana, Flurin Fiscalini, Charlène Raclot et al. · 2021 · SSRN Electronic Journal
  53. INSIGHT OF PANDEMIC COVID-19: DEVELOPMENTS AND CHALLENGES
    Muhammad Akram Muneer, M. Arshad, Ghulam Abbas, Maria Arshad, K. Munir, A. Iqbal, A. Mustafa, Q. Amin, Mumtaz Ahmad Khan, Razia AbdulMajid Qureshi et al. · 2023 · Pakistan Journal of Science
  54. Isolation of Antigen-Specific, Antibody-Secreting Cells Using a Chip-Based Immunospot Array
    Hiroyuki Kishi, Tatsuhiko Ozawa, Hiroshi Hamana, Eiji Kobayashi, Atsushi Muraguchi · 2018 · Methods in molecular biology
  55. Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens
    Cara C. Schafer, Denise Young, Harpreet Singh, Rahul Jayakrishnan, Sreedatta Banerjee, Yingjie Song, Albert L. Dobi, György Petrovics, Sudhir Srivastava, Shiv K. Srivastava et al. · 2023 · Journal of Immunological Methods
  56. Emerging Strategies for Therapeutic Antibody Discovery from Human B Cells
    Saravanan Rajan, William F. Dall’Acqua · 2020 · Advances in experimental medicine and biology
  57. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization
    Rut Valgardsdottir, Irene Cattaneo, Gavino Napolitano, Annibale Raglio, Orietta Spinelli, Silvia Salmoiraghi, Concetta Castilletti, Daniele Lapa, Maria Rosaria Capobianchi, Claudio Farina et al. · 2021 · Antibodies
  58. Detection, sorting, and immortalization of dual expresser lymphocytes from human peripheral blood samples
    Rizwan Ahmed, Kusuma Ananth, Zahra Omidian, Neha Majety, Hao Zhang, Abdel Rahim A. Hamad · 2021 · STAR Protocols
  59. Optimization of Electrofusion Parameters for Producing Hybridomas Synthesizing Human Monoclonal Antibodies
    Marina V. Silkina, Alena S. Kartseva, A. K. Ryabko, Maksim A. Marin, Yana O. Romanenko, Olga V. Kalmantaeva, A. E. Khlyntseva, I. G. Shemyakin, Ivan Alekseevich Dyatlov, Victoria Valerievna Firstova · 2022 · Applied Biochemistry and Microbiology
  60. SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
    Mingtao Liu, Zhiman Liang, Zhangkai Jason Cheng, Li Liu, Qiwen Liu, Yiyin Mai, Hui‐Huang Chen, Baoying Lei, Shangwei Yu, Huihui Chen et al. · 2023 · Reviews in Medical Virology
  61. Insights into the Severe Acute Respiratory Syndrome Coronavirus-2: Transmission, Genome Composition, Replication, Diagnostics and Therapeutics
    Rubi Gupta, Ricky Raj Paswan, Richita Saikia, Basanta Kumar Borah · 2020 · Current Journal of Applied Science and Technology
  62. COVID-19: Between Past and Present
    Areej M. Assaf, Randa N. Haddadin, Amal A. Akour · 2020 · Viral Immunology
  63. Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein
    Claudia Gandolfo, Shibily Prathyumnan, Chiara Terrosi, Gabriele Anichini, Gianni Gori Savellini, Davide Corti, Luisa Bracci, Antonio Lanzavecchia, Gleyder Román‐Sosa, Maria Grazia Cusi · 2021 · Vaccines
  64. Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
    Rong Xiang, Yang Wang, Lili Wang, Xiaoqian Deng, Shanshan Huo, Shibo Jiang, Fei Yu · 2021 · Current Opinion in Virology
  65. Anticuerpos monoclonales
    Antonio A. Carrasco-Yalán · 2021 · Diagnóstico
  66. Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology
    Veronica Strazza, Marco Rossi, Andrea Avati, Giusy Tiseo, Marco Falcone, Maria Grazia Cusi, Francesco Menichetti, Paola Ricciardi‐Castagnoli, Cristina Tinti, Piero Pileri · 2024 · Frontiers in Immunology
  67. Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease
    Michael O Steinitz · 2008 · Expert Opinion on Biological Therapy
  68. The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
    Sophia Steyaert, Lieven Verhoye, Els Beirnaert, Helen Donners, Katrien Fransen, Leo Heyndríckx, Guido Vanham, Geert G Leroux-Roels, Peter Vanlandschoot · 2007 · Journal of Immunological Methods
  69. Selection Strategies I: Monoclonal Antibodies
    Gerhard Moldenhauer · 2007 · Wiley eBooks
  70. A potent SARS-CoV-2 neutralizing antibody recognizing a conserved epitope with broad mutant variant and SARS-CoV activity
    Adam J. Pelzek, Sanam Ebtehaj, James E. Lulo, Lucy Zhang, Olivia Balduf, Lindsay Dolan, Chaohua Zhang, Shengqin Wan, Gang An, Awo Kankam et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation
    Ana Alcaraz‐Serna, Noémie Chillier, Aurélien Trompette, Laura Ermellino, Raphaël Porret, Erica Lana, Rebecca Cecchin, Apiha Shanmuganathan, Seher Guney, Oscar Alfageme-Abello et al. · 2026 · The Journal of Experimental Medicine
  72. Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes
    Hao Wang, Chi Ma, Yanlai Lu, Xu Ji, Yongsheng Pang, Fang Hua, Lianxian Cui, Denian Ba, Wei He · 2013 · Cellular and Molecular Immunology
  73. Relationship Between Human FC γ RIIA rs1801274 G Allele and Risk of Death Among Different SARS-CoV-2 Variants
    Nazanin Moghaddam, Mohammad Taghi Goodarzi, Sina Moghaddam, Fatemeh Sakhaee, Iraj Ahmadi, Enayat Anvari, Abolfazl Fateh · 2023 · Viral Immunology
  74. Optimization of Electrofusion Parameters for Producing Hybridomas Synthesizing Human Monoclonal Antibodies
    Alena S. Kartseva, A. K. Ryabko, Maksim A. Marin, Yana O. Romanenko, Olga V. Kalmantaeva, A. E. Khlyntseva, I. G. Shemyakin, Ivan Alekseevich Dyatlov, Victoria Valerievna Firstova · 2021 · Biotekhnologiya
  75. Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B Cells
    Aisheh I. Ali, Yousef R. Badran, Mona R. Hassuneh, Khaled S. Sanber, Said I. Ismail · 2015 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  76. Regulation and Maintenance of an Adoptive T-Cell Dependent Memory B Cell Pool
    Marie Anson, Inês F. Amado, Marie-Pierre Mailhé, Emmanuel Donnadieu, Sylvie Garcia, François Huetz, António A. Freitas · 2016 · PLoS ONE
  77. Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
    Behnaz Tousizadeh, Sharareh Moghim, Ahmad Reza Salehi Chaleshtori, Maryam Ghanbarian, Mina Mirian, Mansoor Salehi, Sepideh Tousizadeh, Fatemeh Zaboli · 2017 · Advanced Biomedical Research
  78. SARS Coronavirus Pathogenesis and Therapeutic Treatment Design
    Timothy Patrick Sheahan, Ralph Steven Baric · 2009 · Springer eBooks
  79. Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses
    Luis Enjuanes, Marta L. DeDiego, Enrique Alarcón Álvarez, Carmen Capiscol, Ralph Steven Baric · 2014 · ASM Press eBooks
  80. Screening of Antigen-Specific Antibody-Secreting Cells
    Hiroyuki Kishi, Aishun Jin, Tatsuhiko Ozawa, Kazuto Tajiri, Tsutomu Obata, Atsushi Muraguchi · 2012 · Methods in molecular biology
  81. THE DETECTION OF ANTIBODIES SECRETED BY MICROFLUIDICALLY TRAPPED BIOLOGICAL CELLS VIA EXTRAORDINARY OPTICAL DETECTION BASED NANOSCALE IMMUNOBIOSENSING ARRAYS
    Sean F. Romanuik, Samantha M. Grist, Bonnie L. Gray, N. Gulzar, Jamie Kathleen Scott, Donna Hohertz, Karen L Kavanagh, Rajinder Nirwan, Cheng Hui, Alexandre G. Brolo et al. · 2010
  82. Structure of ClfA002 in Complex With Neutralizing Antibody AZD7745 Provides Insight into Its Broad Neutralization Mechanism in Staphylococcus aureus Infection
    Christine Tkaczyk, Tal Keren‐Kaplan, Adam Gamson, Paul Warrener, Е. А. Семенова, Kim Rosenthal, Arnita S. Barnes, Bahar Ahani, Bret R. Sellman, Ondřej Podlaha et al. · 2025 · The Journal of Infectious Diseases
  83. Monoclonal Antibody-Based Therapeutics for Melioidosis and Glanders
    A. · 2011 · American Journal of Immunology
  84. Site‐specific serology unveils cross‐reactive monoclonal antibodies targeting influenza A hemagglutinin epitopes
    Philipp Paparoditis, Alexander Fruehwirth, Kajetana Bevc, Jun Siong Low, Josipa Jerak, Laura Terzaghi, Mathilde Foglierini, Blanca Fernandez, David Jarrossay, Davide Corti et al. · 2024 · European Journal of Immunology
  85. SARS
    Bart L. Haagmans, Albert D. M. E. Osterhaus · 2009 · Elsevier eBooks
  86. Factors affecting SARS-CoV-2 (COVID-19) Pandemic, including Zoonotic, Human Transmission and Chain of Infection. Reducing Public health Risk by Serum Antibody Testing, Avoiding Screening in Unhygienic Places and False PCR Reporting. A Scientific Review
    Kamran Mahmood Ahmed Aziz, Abdullah Othman, Waleed Abdullah Alqahtani, Sumaiya Azhar · 2021 · Iberoamerican Journal of Medicine
  87. Orthotopic PDX and CDX Mice Model for Cancer Stem Cell Research
    Jayanta Das, Madhumita Das · 2022 · Handbook of Animal Models and its Uses in Cancer Research
  88. An oral mucosal DNA vaccine for SARS coronavirus infections.
    Kwok‐Yung Yuen, Patrick C. Y. Woo, Susanna K. P. Lau · 2009 · PubMed
  89. Analytic Vaccinology: Antibody-Driven Design of a Human Cytomegalovirus Subunit Vaccine
    Anna Kabanova, Daniele Lilleri · 2016 · Methods in molecular biology
  90. The other side of the coin: Leveraging Epstein–Barr virus in research and therapy
    Fenggang Yu, Wei Jian Tan, Yanan Lu, Paul A. MacAry, Kwok Seng Loh · 2016 · Oral Oncology
  91. A Simple Red Blood Cell Lysis Method for the Establishment of B Lymphoblastoid Cell Lines
    Xi Liu, Chong‐Feng Xu, Ziyuan Duan · 2017 · Journal of Visualized Experiments
  92. Yesterday, Today And The Future Of Monoclonal Antibody Technology
    S. Mert Selimoglu, Murat Kasap, Gürler Akpınar, Aynur Karadenizli · 2016 · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
  93. Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting
    Fabio Nicolini, Martine Bocchini, Davide Angeli, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Massimiliano Mazza · 2020 · Cancers
  94. European Immunogenicity Platform 11th Open Scientific Symposium on Immunogenicity of Biopharmaceuticals
    Sophie Tourdot, Carolina B Quaglia, Paul Chamberlain, Anne Searls De Groot, Nikki Dellas, Eric Guillemare, Arno Kromminga, Gregor P. Lotz, Federico Mingozzi, Luca Piccoli et al. · 2020 · Bioanalysis
  95. Production of PfEMP1-Specific Human Monoclonal Antibodies from Naturally Immune Individuals
    Melanie R. Walker, Lea Klingenberg Barfod · 2022 · Methods in molecular biology
  96. Technologies for Making New Vaccines
    Simone Pecetta, Sohail Ahmed, Ronald W. Ellis, Rino Rappuoli · 2023 · Elsevier eBooks
  97. A Review on Role of Inflammation in Coronavirus Disease
    Arezoo Lotfi, Pouran Hajian, Laleh Abbasi, Morad Kohandel Gargari, Najmeh Nameh Goshay Fard, Delaram Naderi · 2024 · Endocrine Metabolic & Immune Disorders - Drug Targets
  98. Characteristics of B Cells and B Cell Responses in Aged Individuals
    Henrik E. Mei, Andreas Radbruch · 2011 · Springer eBooks
  99. Human monoclonal antibodies for prophylaxis and therapy of viral infection
    Jan ter Meulen, Jaap Goudsmit · 2006 · Kluwer Academic Publishers eBooks
  100. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation
    Seidu A. Richard, Sylvanus Kampo, Marian Sackey, Maite Esquijarosa Hechavarria, Alexis D. B. Buunaaim, Eugene Dogkotenge Kuugbee, Thomas Winsum Anabah · 2020 · Current Stem Cell Research & Therapy